首页> 外文学位 >In vivo biocompatibility evaluation of composite polymeric materials for use in a novel artificial heart valve.
【24h】

In vivo biocompatibility evaluation of composite polymeric materials for use in a novel artificial heart valve.

机译:用于新型人工心脏瓣膜的复合聚合物材料的体内生物相容性评估。

获取原文
获取原文并翻译 | 示例

摘要

A novel trileaflet polymer valve is a composite design of a biostable polymer poly(styrene-isobutylene-styrene) (SIBS) with a reinforcement polyethylene terephthalate (PET) fabric. Surface roughness and hydrophilicity vary with fabrication methods and influence leaflet biocompatibility. The purpose of this study was to investigate the biocompatibility of this composite material using both small animal (nonfunctional mode) and large animal (functional mode) models.;Composite samples were manufactured using dip coating and solvent casting with different coating thickness (251mum and 50mum). Sample's surface was characterized through qualitative SEM observation and quantitative surface roughness analysis. A novel rat abdominal aorta model was developed to test the composite samples in a similar pulsatile flow condition as its intended use. The sample's tissue response was characterized by histological examination. Among the samples tested, the 25mum solvent-cast sample exhibited the smoothest surface and best biocompatibility in terms of tissue capsulation thickness, and was chosen as the method for fabrication of the SIBS valve. Phosphocholine was used to create a hydrophilic surface on selected composite samples, which resulted in improved blood compatibility.;Four SIBS valves (two with phosphocholine modification) were implanted into sheep. Echocardiography, blood chemistry, and system pathology were conducted to evaluate the valve's performance and biocompatibility. No adverse response was identified following implantation. The average survival time was 76 days, and one sheep with the phosphocholine modified valve passed the FDA minimum requirement of 140 days with approximately 20 million cycles of valve activity. The explanted valves were observed under the aid of a dissection microscope, and evaluated via histology, SEM and X-ray. Surface cracks and calcified tissue deposition were found on the leaflets.;In conclusion, we demonstrated the applicability of using a new rat abdominal aorta model for biocompatibility assessment of polymeric materials. A smooth and complete coating surface is essential for the biocompatibility of PET/SIBS composite, and surface modification using phosphocholine improves blood compatibility. Extrinsic calcification was identified on the leaflets and was associated with regions of surface cracks.
机译:一种新颖的三叶聚合物瓣膜是生物稳定的聚合物聚(苯乙烯-异丁烯-苯乙烯)(SIBS)与增强聚对苯二甲酸乙二醇酯(PET)织物的复合设计。表面粗糙度和亲水性随制造方法的不同而变化,并影响小叶的生物相容性。这项研究的目的是使用小动物模型(非功能模式)和大动物模型(功能模式)研究这种复合材料的生物相容性。复合样品是通过浸涂和溶剂流延制成的,具有不同的涂层厚度(251μm和50mum) )。通过定性SEM观察和定量的表面粗糙度分析来表征样品的表面。开发了新型大鼠腹主动脉模型,以在与预期用途相似的脉动流动条件下测试复合样品。通过组织学检查表征样品的组织反应。在测试的样品中,就组织包封厚度而言,25mum溶剂浇铸样品表现出最光滑的表面和最佳的生物相容性,因此被选作SIBS瓣膜的制造方法。用磷胆碱在选定的复合样品上形成亲水表面,从而改善血液相容性。将四个SIBS瓣膜(两个经过磷胆碱修饰的瓣膜)植入绵羊体内。进行了超声心动图,血液化学和系统病理学评估瓣膜的性能和生物相容性。植入后未发现不良反应。平均生存时间为76天,一只拥有磷酸胆碱修饰瓣膜的绵羊通过了FDA的最低要求140天,瓣膜活动周期约为2000万次。在解剖显微镜的帮助下观察外植瓣膜,并通过组织学,SEM和X射线评估。在小叶上发现了表面裂纹和钙化的组织沉积。;总而言之,我们证明了使用新的大鼠腹主动脉模型进行高分子材料生物相容性评估的适用性。光滑且完整的涂层表面对于PET / SIBS复合材料的生物相容性至关重要,而使用磷胆碱进行的表面修饰可改善血液相容性。在小叶上发现了外部钙化,并与表面裂纹区域相关。

著录项

  • 作者

    Wang, Qiang.;

  • 作者单位

    Florida International University.;

  • 授予单位 Florida International University.;
  • 学科 Engineering Biomedical.
  • 学位 Ph.D.
  • 年度 2008
  • 页码 182 p.
  • 总页数 182
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号